Trials / Completed
CompletedNCT03610269
Spot-Check Noninvasive Hemoglobin (SpHb) Clinical Validation of INVSENSOR00026
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 143 (actual)
- Sponsor
- Masimo Corporation · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The primary objective of this clinical investigation is to evaluate the accuracy of using Masimo's INVSENSOR00026 Pulse CO-Oximeter and Sensor to measure hemoglobin, as compared to hemoglobin measurements obtained from various lab analyzer(s) and point of care device(s).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | INVSENSOR00026 (Pulse CO-Oximeter and sensor) | Noninvasive Pulse CO-Oximeter and sensor that measures noninvasive hemoglobin (SpHb) |
Timeline
- Start date
- 2018-08-01
- Primary completion
- 2018-08-16
- Completion
- 2018-08-16
- First posted
- 2018-08-01
- Last updated
- 2019-06-25
- Results posted
- 2019-06-25
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT03610269. Inclusion in this directory is not an endorsement.